Spatiotemporal Alterations in Working Memory-Related Beta Band Neuromagnetic Activity of Patients With Schizophrenia On and Off Antipsychotic Medication: Investigation With MEG

Schizophr Bull. 2023 May 3;49(3):669-678. doi: 10.1093/schbul/sbac178.

Abstract

Background and hypothesis: We used the uniquely high combined spatial and temporal resolution of magnetoencephalography to characterize working memory (WM)-related modulation of beta band activity in neuroleptic-free patients with schizophrenia in comparison to a large sample of performance-matched healthy controls. We also tested for effects of antipsychotic medication on identified differences in these same patients.

Study design: Inpatients with schizophrenia (n = 21) or psychotic disorder not otherwise specified (n = 4) completed N-back and control tasks during magnetoencephalography while on placebo and during antipsychotic medication treatment, in a blinded, randomized, counterbalanced manner. Healthy, performance-matched controls (N = 100) completed the same tasks. WM-related neural activation was estimated as beta band (14-30 Hz) desynchronization throughout the brain in successive 400 ms time windows. Voxel-wise statistical comparisons were performed between controls and patients while off-medication at each time window. Significant clusters resulting from this between-groups analysis were then used as regions-of-interest, the activations of which were compared between on- and off-medication conditions in patients.

Study results: Controls showed beta-band desynchronization (activation) of a fronto-parietal network immediately preceding correct button press responses-the time associated with WM updating and task execution. Altered activation in medication-free patients occurred largely during this time, in prefrontal, parietal, and visual cortices. Medication altered patients' neural responses such that the activation time courses in these regions-of-interest more closely resembled those of controls.

Conclusions: These findings demonstrate that WM-related beta band alterations in schizophrenia are time-specific and associated with neural systems targeted by antipsychotic medications. Future studies may investigate this association by examining its potential neurochemical basis.

Trial registration: ClinicalTrials.gov NCT00001247 NCT00001921 NCT00004571.

Keywords: cognition; prefrontal cortex; psychosis.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Antipsychotic Agents* / pharmacology
  • Antipsychotic Agents* / therapeutic use
  • Brain Mapping
  • Humans
  • Magnetic Resonance Imaging
  • Magnetoencephalography
  • Memory, Short-Term / physiology
  • Neuropsychological Tests
  • Schizophrenia* / complications
  • Schizophrenia* / drug therapy

Substances

  • Antipsychotic Agents

Associated data

  • ClinicalTrials.gov/NCT00001247
  • ClinicalTrials.gov/NCT00001921
  • ClinicalTrials.gov/NCT00004571